Project Grant R01AI191576
Award Date 8/18/25
Completion Date 7/31/30
Dollars Obligated $1.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Florida, USA
Similar Awards
- This $657,907 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The project aims to conduct a multi-level, longitudinal analysis examining the impact of expanding pharmacists' scope of practice on increasing uptake and retention of pre-exposure prophylaxis (PrEP) for HIV prevention. The research will utilize staggered difference-in-differences and agent-based...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $962,973 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Duke University for the "Pharmacists for Prevention (P4P): Harnessing the Role of Pharmacists in Ending the HIV Epidemic Through Collaboration with Pharmacy Schools" project. The project aims to develop and implement a comprehensive curriculum to train pharmacy students in the South on HIV prevention, including...
- This Project Grant award from the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) provides $242,827 to Empowerx, Inc. to develop and assess the "PEP/PREP via Pharmacist-Prescribing Implementation (PEPPI)" software. The project aims to support the implementation of effective and sustainable pharmacist-prescribed post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP) services to improve access and adherence to these highly effective HIV...
- This $1,272,341 cooperative agreement from the Centers for Disease Control and Prevention will support efforts to promote pre-exposure prophylaxis (PrEP) adherence among men who have sex with men of color. Awarded under the HIV Demonstration, Research, Public and Professional Education Projects program (CFDA 93.941), the University of North Carolina at Chapel Hill will work to develop and test improved HIV prevention strategies from September 2021 through October 2022. A subaward of $250,000...
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $743,492 to Kaiser Foundation Hospitals to conduct a longitudinal cohort study evaluating the effects of HIV pre-exposure prophylaxis (PrEP) on cardiovascular, kidney, and metabolic health. The study aims to assess the impact of PrEP, particularly the use of tenofovir-based regimens, on the risk of developing cardiovascular...
- The federal Project Grant award of $193,754 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports the development of an implementation strategy for pre-exposure prophylaxis (PrEP) based on academic detailing to improve PrEP prescribing and persistence among adolescents and young adults in pediatric primary care settings. The project, titled "ACADEMIC DETAILING TO OPTIMIZE PREP IMPLEMENTATION IN PEDIATRIC PRIMARY CARE...
- This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants (CFDA 93.242) program, totaling $191,117, will fund the development and pilot of an anti-stigma intervention to improve communications between U.S. pharmacy staff and people seeking pre-exposure prophylaxis (PrEP) for HIV prevention. The key products and services to be delivered include: Qualitative assessments of the experiences and preferences of pharmacists, pharmacy...
- This $691,620 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to develop a web-based intervention to promote pre-exposure prophylaxis (PrEP) awareness and demand among women in the Southeastern United States. The project involves three key components: Developing a social media targeting approach to engage women with indications of PrEP need. This will include focus group discussions and a social media...
- This Project Grant award from the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) provides $731,738 to George Washington University to conduct a pilot feasibility study on integrating pre-exposure prophylaxis (PrEP) into emergency departments using decision support tools. The project aims to develop, validate, and pilot test a patient-centered decision support tool to promote PrEP persistence among high-risk populations after emergency or urgent care visits. The...
- The National Institutes of Health (NIH) awarded a $250,000 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Fred Hutchinson Cancer Center in Seattle, Washington. The grant funds a hybrid effectiveness-implementation cluster-randomized controlled trial at 20 pharmacies in Kenya to evaluate whether introducing a remote nurse to assist with pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) delivery can improve clinical and implementation outcomes...